Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K120994
    Date Cleared
    2012-08-07

    (127 days)

    Product Code
    Regulation Number
    866.2560
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The BD BACTEC Plus PRIME Aerobic/F blood culture medium is used in a qualitative procedure for the aerobic culture and recovery of microorganisms (bacteria and yeast) from blood. The principal use of this medium is with the BD BACTEC fluorescent series instruments.

    Device Description

    The sample to be tested is inoculated into one or more vials which are inserted into the BACTEC fluorescent series instrument for incubation and periodic reading. Each vial contains a chemical sensor which can detect increases in CO2 produced by the growth of microorganisms. The sensor is monitored by the instrument every ten minutes for an increase in its fluorescence, which is proportional to the amount of CO2 present. A positive reading indicates the presumptive presence of viable microorganisms in the vial. Detection is limited to microorganisms that will grow in a particular type of medium.

    Resins have been described for the treatment of blood specimens both prior to and after their inoculation into culture media. Resins have been incorporated into BACTEC culture media to enhance recovery of organisms without a need for special processing.

    AI/ML Overview

    Here's an analysis of the provided text regarding the BD BACTEC Plus PRIME Aerobic/F medium:

    Key Takeaway: This document is a 510(k) summary for a medical device (blood culture medium) seeking FDA clearance. It's a "substantial equivalence" claim, meaning the device is compared to a legally marketed predicate device rather than a ground-up demonstration of safety and effectiveness as in a PMA. Therefore, the "acceptance criteria" and "study that proves the device meets the acceptance criteria" are framed within this comparison to the predicate device. The performance data focuses on demonstrating that the new device performs equivalently or, in some cases, better than the predicate.


    1. Acceptance Criteria and Reported Device Performance

    The acceptance criteria are implicitly defined by achieving performance that is not significantly different or clinically equivalent to the predicate device, or statistically better where a difference is desirable (like antimicrobial neutralization).

    Acceptance Criteria (Implicit)Reported Device Performance
    Time to Detection (TTD): No clinically relevant difference compared to predicate.Median TTD difference: 0.92 hours (55 minutes) between new and predicate device (for 333 paired positive sets). For 10-100 CFU inoculum, ~80% of 244 paired sets had TTD difference
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1